Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.52 |
| ▸ | MME | P08473 | 4/20 | 0.48 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | CPA1 | P15085 | 1/20 | 0.48 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
| ▸ | CTRB1 | P17538 | 5/20 | 0.42 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17545410 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL380599 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL5161799 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL29898350 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL380600 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL9698824 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL574263 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL476353 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL159553 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| Water SCHEMBL23711627 | 0.98 | DPP4 (0.50) | DPP4MMEACECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 552 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122012392-A | NK cell culture kit and NK cell culture method using same | 广东普罗凯融生物医药科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4642491-A1 | METHOD FOR GLYCOPROTEIN MODIFICATION | Honeybear Biosciences Inc. (TW) | 2025-11-05 | — | — | EP | claimed |
| EP-4623937-A1 | ANTI-TUMOR COMPOUND AND USE THEREOF | Minghui Pharmaceutical (Hangzhou) Limited (CN) | 2025-10-01 | — | — | EP | claimed |
| WO-2025126157-A1 | ANTI-IL-1RAP BINDING DOMAINS AND ANTIBODY-DRUG CONJUGATES THEREOF | ADVESYA (FR) | 2025-06-19 | — | — | WO | claimed |
| WO-2025031307-A1 | MULTIDRUG LINKER AND ANTIBODY-DRUG CONJUGATE | 上海华藕生物医药有限公司 | 2025-02-13 | — | — | WO | claimed |
| WO-2024250985-A1 | TOLL-LIKE RECEPTOR AGONIST HETEROCYCLIC DERIVATIVE, PREPARATION THEREOF, AND USE THEREOF | 上海维申医药有限公司 | 2024-12-12 | — | — | WO | claimed |
| WO-2024250984-A1 | ANTIBODY-DRUG CONJUGATE, AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION THEREFOR AND USE THEREOF | 上海维申医药有限公司 | 2024-12-12 | — | — | WO | claimed |
| US-20240293519-A1 | Universal mRNA Vaccine to Treat Dementia-Causing Neurodegenerative Disorders | RNA Therapeutics, Inc. (US) | 2024-09-05 | — | — | US | claimed |
| US-20240285742-A1 | Universal mRNA Antimalarial Vaccine | RNA Therapeutics, Inc. (US) | 2024-08-29 | — | — | US | claimed |
| CN-118384255-A | Application of walnut peptide in preparation of obesity improving medicine | 云南中医药大学 | 2024-07-26 | — | — | CN | claimed |
| EP-0995492-B1 | Product able to transform a toxic, corrosive or environmentally harmful liquid product into a non-aggressive or harmless residue | MEYER MARIE-CLAUDE (FR) | 2003-05-28 | — | — | EP | claimed |
| EP-1235261-A1 | POLISHING COMPOUND FOR SEMICONDUCTOR CONTAINING PEPTIDE | Seimi Chemical Co., Ltd. (JP) | 2002-08-28 | — | — | EP | claimed |
| US-6429220-B1 | COMPRISES AN ISOTHIAZOLONE COMPOUND AND AN AMINOCARBOXYLIC ACID | KURITA WATER INDUSTRIES LTD. (JP) | 2002-08-06 | — | — | US | claimed |
| US-6239111-B1 | DRUG FOR TREATING BRAIN DISEASES, ENABLES PREVENTION OR TREATMENT OF DEMENTIA AND SIMILAR DISEASES CAUSED BY DEGENERATION OR SLOUGHING OF NEURONS, AN ALLY SULFIDE, SULFOXIDE OR SULFONE | WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-29 | — | — | US | claimed |
| EP-0674632-A1 | AMINOACID DERIVATIVES OF HETEROCYCLES AS PROTEIN KINASE C INHIBITORS | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1995-10-04 | — | — | EP | claimed |
| WO-1994014798-A1 | AMINOACID DERIVATIVES OF HETEROCYCLES AS PROTEIN KINASE C INHIBITORS | Gödecke Aktiengesellschaft (DE) | 1994-07-07 | — | — | WO | claimed |
| EP-0493511-A1 | BIOSENSOR AND PROCESS FOR PRODUCING IT | PITTNER, Fritz, Ass.Prof.Doz.Dr. (AT) | 1992-07-08 | — | — | EP | claimed |
| EP-0199432-B1 | ASSAYING METHOD FOR PRIMARY AMINES USING AROMATIC DIALDEHYDES | OREAD LABORATORIES, INC. (US) | 1991-05-29 | — | — | EP | claimed |
| WO-1991006625-A1 | BIOSENSOR AND PROCESS FOR PRODUCING IT | PITTNER FRITZ (AT) | 1991-05-16 | — | — | WO | claimed |
| US-4910314-A | Containing a benz(f)isoindole ring | OREAD LABORATORIES, INC. (US) | 1990-03-20 | — | — | US | claimed |